Citius Pharmaceuticals CTXR
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 0.78 | 100.50 | -0.38 | -9,019 | -8 | |
| 2025Q3 | 1.24 | 100.63 | -0.11 | -8,437 | -8 | |
| 2025Q2 | 1.59 | 100.24 | -0.69 | -8,788 | -9 | |
| 2025Q1 | 1.49 | 100.12 | -1.28 | -11,261 | -11 | |
| 2024Q4 | 4.00 | 100.23 | -1.30 | -10,040 | -10 | |
| 2024Q3 | 12.52 | 101.07 | -1.60 | -11,050 | -11 | |
| 2024Q2 | 14.59 | 101.97 | -1.58 | -10,634 | -11 | |
| 2024Q1 | 22.43 | 130.60 | -1.34 | -10,970 | -9 | |
| 2023Q4 | 18.91 | 102.80 | -1.45 | -9,341 | -9 | |
| 2023Q3 | 17.11 | 103.32 | -1.82 | -10,125 | -10 | |
| 2023Q2 | 30.00 | 104.04 | -1.25 | -8,672 | -8 | |
| 2023Q1 | 29.25 | 102.92 | -2.00 | -10,685 | -11 | |
| 2022Q4 | 19.75 | 210.14 | -0.50 | -7,250 | -4 | |
| 2022Q3 | 30.25 | 101.82 | -1.25 | -7,550 | -8 | |
| 2022Q2 | 23.00 | 100.60 | -1.75 | -8,917 | -9 | |
| 2022Q1 | 44.75 | 100.40 | -1.25 | -7,591 | -8 | |
| 2021Q4 | 38.50 | 100.37 | -1.50 | -9,259 | -9 | |
| 2021Q3 | 50.75 | 104.88 | -0.75 | -5,203 | -5 | |
| 2021Q2 | 87.00 | 102.80 | -1.00 | -5,984 | -6 | |
| 2021Q1 | 44.50 | 101.68 | -0.25 | -4,188 | -4 |